These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25359562)

  • 1. mRNA transcript therapy.
    Weissman D
    Expert Rev Vaccines; 2015 Feb; 14(2):265-81. PubMed ID: 25359562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA-based therapeutics--developing a new class of drugs.
    Sahin U; Karikó K; Türeci Ö
    Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.
    Vallazza B; Petri S; Poleganov MA; Eberle F; Kuhn AN; Sahin U
    Wiley Interdiscip Rev RNA; 2015; 6(5):471-99. PubMed ID: 26061157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.
    Deering RP; Kommareddy S; Ulmer JB; Brito LA; Geall AJ
    Expert Opin Drug Deliv; 2014 Jun; 11(6):885-99. PubMed ID: 24665982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The messenger's great message for vaccination.
    Pascolo S
    Expert Rev Vaccines; 2015 Feb; 14(2):153-6. PubMed ID: 25586101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ReNAissanCe of mRNA-based cancer therapy.
    Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
    Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Materials for non-viral intracellular delivery of messenger RNA therapeutics.
    Kauffman KJ; Webber MJ; Anderson DG
    J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    Tombácz I; Weissman D; Pardi N
    Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA-based vaccines.
    Pascolo S
    Expert Opin Biol Ther; 2004 Aug; 4(8):1285-94. PubMed ID: 15268662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.
    Karkada M; Weir GM; Quinton T; Fuentes-Ortega A; Mansour M
    Vaccine; 2010 Aug; 28(38):6176-82. PubMed ID: 20656034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere J; Dewitte H; De Smedt SC; Remaut K
    Drug Discov Today; 2016 Jan; 21(1):11-25. PubMed ID: 26210957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.
    Karikó K; Muramatsu H; Ludwig J; Weissman D
    Nucleic Acids Res; 2011 Nov; 39(21):e142. PubMed ID: 21890902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-based drugs and vaccines.
    Lundstrom K
    Expert Rev Vaccines; 2015 Feb; 14(2):253-63. PubMed ID: 25220891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and advances towards the rational design of mRNA vaccines.
    Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
    Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of mRNA-based vaccines.
    Iavarone C; O'hagan DT; Yu D; Delahaye NF; Ulmer JB
    Expert Rev Vaccines; 2017 Sep; 16(9):871-881. PubMed ID: 28701102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.